» Articles » PMID: 16006558

Fragile X Mental Retardation Protein (FMRP) Binds Specifically to the Brain Cytoplasmic RNAs BC1/BC200 Via a Novel RNA-binding Motif

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2005 Jul 12
PMID 16006558
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Fragile X mental retardation protein (FMRP), the protein responsible for the fragile X syndrome, is an RNA-binding protein involved in localization and translation of neuronal mRNAs. One of the RNAs known to interact with FMRP is the dendritic non-translatable brain cytoplasmic RNA 1 BC1 RNA that works as an adaptor molecule linking FMRP and some of its regulated mRNAs. Here, we showed that the N terminus of FMRP binds strongly and specifically to BC1 and to its potential human analog BC200. This region does not contain a motif known to specifically recognize RNA and thus constitutes a new RNA-binding motif. We further demonstrated that FMRP recognition involves the 5' stem loop of BC1 and that this is the region that exhibits complementarity to FMRP target mRNAs, raising the possibility that FMRP plays a direct role in BC1/mRNA annealing.

Citing Articles

RNA in axons, dendrites, synapses and beyond.

Taylor R, Nikolaou N Front Mol Neurosci. 2024; 17:1397378.

PMID: 39359690 PMC: 11446172. DOI: 10.3389/fnmol.2024.1397378.


FMRP cooperates with miRISC components to repress translation and regulate neurite morphogenesis in .

Kaul N, Pradhan S, Boin N, Mason M, Rosales J, Starke E RNA Biol. 2024; 21(1):11-22.

PMID: 39190491 PMC: 11352701. DOI: 10.1080/15476286.2024.2392304.


Overview: Research on the Genetic Architecture of the Developing Cerebral Cortex in Norms and Diseases.

Momoi M Methods Mol Biol. 2024; 2794:1-12.

PMID: 38630215 DOI: 10.1007/978-1-0716-3810-1_1.


Variable expression of and in the human brain: Implications for gene restorative therapies.

Zito A, Lee J Proc Natl Acad Sci U S A. 2024; 121(9):e2312757121.

PMID: 38386709 PMC: 10907246. DOI: 10.1073/pnas.2312757121.


The Role of Non-coding RNAs in Alzheimer's Disease: Pathogenesis, Novel Biomarkers, and Potential Therapeutic Targets.

Saleh O, Albakri K, Altiti A, Abutair I, Shalan S, Mohd O CNS Neurol Disord Drug Targets. 2023; 23(6):731-745.

PMID: 37211844 DOI: 10.2174/1871527322666230519113201.